Near Infrared Light‐Activatable Platelet‐Mimicking NIR‐II NO Nano‐Prodrug for Precise Atherosclerosis Theranostics
Advanced Science · 2024-01 · 11 (3)
DOI: 10.1002/advs.202304994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.11.2023. Verfasst von Yun Chai und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Prodrugs, Atherosclerosis. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Double First Class" University Project, The Jiangsu Funding Program for Excellent Postdoctoral Talent.
Abstract (Originalsprache)
Atherosclerosis is a chronic inflammatory disease that affects arteries and is the main cause of cardiovascular disease. Atherosclerotic plaque formation is usually asymptomatic and does not manifest until the occurrence of clinical events. Therefore, early diagnosis and treatment of atherosclerotic plaques is particularly important. Here, a series of NIR‐II fluorescent dyes (RBT‐NH) are developed for three photoresponsive NO prodrugs (RBT‐NO), which can be controllably triggered by 808 nm laser to release NO and turn on the NIR‐II emission in the clinical medicine “therapeutic window”. Notably, RBT3‐NO is selected for its exhibited high NO releasing efficiency and superior fluorescence signal enhancement. Subsequently, a platelet‐mimicking nano‐prodrug system (RBT3‐NO‐PEG@PM) is constructed by DSPE‐mPEG 5k and platelet membrane (PM) for effectively targeted diagnosis and therapy of atherosclerosis in mice. The results indicate that this platelet‐mimicking NO nano‐prodrug system can reduce the accumulation of lipids at the sites of atherosclerotic plaques, improve the inflammatory response at the lesion sites, and promote endothelial cell migration, thereby slowing the progression of plaques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China.
- School of Mechanical Engineering, Southeast University, Nanjing, 211189, China.
ORCID-Profile: Yi Liu
Förderung
- National Natural Science Foundation of China
- "Double First Class" University Project
- The Jiangsu Funding Program for Excellent Postdoctoral Talent
- The 16th Six Talent Peaks Project of Jiangsu Province
Zitieren
APA
Chai, Y., Shangguan, L., Yu, H., Sun, Y., Huang, X., Zhu, Y., Wang, H. Y., & Liu, Y. (2024). Near Infrared Light‐Activatable Platelet‐Mimicking NIR‐II NO Nano‐Prodrug for Precise Atherosclerosis Theranostics. Advanced Science, 11(3). https://doi.org/10.1002/advs.202304994
Vancouver
Chai Y, Shangguan L, Yu H, Sun Y, Huang X, Zhu Y, et al. Near Infrared Light‐Activatable Platelet‐Mimicking NIR‐II NO Nano‐Prodrug for Precise Atherosclerosis Theranostics. Advanced Science. 2024;11(3). doi:10.1002/advs.202304994
BibTeX
@article{Chai2024,
author = {Chai, Yun and Shangguan, Lina and Yu, Hui and Sun, Ye and Huang, Xiaoyan and Zhu, Yanyan and Wang, Hai-Yan and Liu, Yi},
title = {Near Infrared Light‐Activatable Platelet‐Mimicking NIR‐II NO Nano‐Prodrug for Precise Atherosclerosis Theranostics},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {3},
doi = {10.1002/advs.202304994}
}
EUVIMED